With THRIVE DFT Ultra 2.0, Le-Vel is introducing an innovative product with Derma Fusion Technology, or DFT. With this delivery system, the skin is infused with a THRIVE Premium Lifestyle Formula in an effortless, comfortable way for prolonged periods of time.
Some of the ingredients that go into the making of the formula include garcinia cambogia, green coffee bean extract, antioxidant-rich green tea extract CoQ10, and white willow bark, which come together to provide nutritional support, appetite management, mental clarity, plus boosted energy and circulation in the body. Notably, THRIVE DFT Ultra 2.0 provides improved permeation technology, a greater concentration of Forslean (a nutrient in support of weight management) in comparison to the 1.0 version, as well as the highest concentration of garcinia extract and Forslean of DFT formula.
This highly anticipated new product from Le-Vel generated over $1 million in sales in its first hour.
Wearable Wellness Patches
THRIVE DFT Ultra 2.0 is Powered by Derma Fusion Technology
Trend Themes
1. Derma Fusion Technology - Opportunity for developing innovative delivery systems that infuse nutrients into the skin for prolonged periods of time.
2. Wearable Wellness Patches - Potential for creating patches that provide nutritional support, appetite management, mental clarity, and energy boost for enhanced well-being.
3. Improved Permeation Technology - Opportunity for developing new technologies that enhance the absorption of nutrients through the skin for improved effectiveness.
Industry Implications
1. Nutritional Supplements - Disruptive innovation opportunities in the nutritional supplement industry by creating patches that provide targeted nutrient support.
2. Fitness & Wellness - Opportunity for disruptive innovation in the fitness and wellness industry by developing wearable patches that offer personalized wellness benefits.
3. Pharmaceuticals - Opportunity for pharmaceutical companies to explore the use of derma fusion technology for enhanced drug delivery and increased patient compliance.